1. Home
  2. RPRX vs ZBRA Comparison

RPRX vs ZBRA Comparison

Compare RPRX & ZBRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • ZBRA
  • Stock Information
  • Founded
  • RPRX 1996
  • ZBRA 1969
  • Country
  • RPRX United States
  • ZBRA United States
  • Employees
  • RPRX N/A
  • ZBRA N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • ZBRA Industrial Machinery/Components
  • Sector
  • RPRX Health Care
  • ZBRA Industrials
  • Exchange
  • RPRX Nasdaq
  • ZBRA Nasdaq
  • Market Cap
  • RPRX 13.9B
  • ZBRA 14.5B
  • IPO Year
  • RPRX 2020
  • ZBRA 1991
  • Fundamental
  • Price
  • RPRX $36.46
  • ZBRA $323.72
  • Analyst Decision
  • RPRX Strong Buy
  • ZBRA Buy
  • Analyst Count
  • RPRX 3
  • ZBRA 9
  • Target Price
  • RPRX $47.33
  • ZBRA $326.33
  • AVG Volume (30 Days)
  • RPRX 4.4M
  • ZBRA 464.7K
  • Earning Date
  • RPRX 08-07-2025
  • ZBRA 08-05-2025
  • Dividend Yield
  • RPRX 2.42%
  • ZBRA N/A
  • EPS Growth
  • RPRX 37.60
  • ZBRA 109.28
  • EPS
  • RPRX 2.45
  • ZBRA 10.57
  • Revenue
  • RPRX $2,263,845,000.00
  • ZBRA $5,114,000,000.00
  • Revenue This Year
  • RPRX $29.35
  • ZBRA $7.67
  • Revenue Next Year
  • RPRX $7.58
  • ZBRA $6.08
  • P/E Ratio
  • RPRX $14.83
  • ZBRA $30.63
  • Revenue Growth
  • RPRX 1.13
  • ZBRA 17.45
  • 52 Week Low
  • RPRX $24.05
  • ZBRA $205.73
  • 52 Week High
  • RPRX $36.43
  • ZBRA $427.76
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 64.64
  • ZBRA 73.36
  • Support Level
  • RPRX $35.01
  • ZBRA $306.28
  • Resistance Level
  • RPRX $36.33
  • ZBRA $313.16
  • Average True Range (ATR)
  • RPRX 0.63
  • ZBRA 6.93
  • MACD
  • RPRX 0.05
  • ZBRA 2.10
  • Stochastic Oscillator
  • RPRX 90.72
  • ZBRA 93.95

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About ZBRA Zebra Technologies Corporation

Zebra Technologies is a leading provider of automatic identification and data capture technology to enterprises. Its solutions include barcode printers and scanners, mobile computers, and workflow optimization software. The firm primarily serves the retail, transportation logistics, manufacturing, and healthcare markets, designing custom solutions to improve efficiency at its customers.

Share on Social Networks: